Home - Maple Respiratory

We Will Change The Lives Of

5 Million People

I AM A…

Patient

Find out how our passionate MRG health professionals provide quality care for your chronic lung disease and sleep disorder breathing needs.

Find Out More

Patient centered-care is achievable and real. We have demonstrated that is not enough to treat someone’s primary disease state (sleep and/or respiratory health), along with their comorbidities we address the individual’s needs including their dietary habits, pharmacological intake, physical, emotional and psychological challenges. Here are our programs and services. How can we work together?

Find Out More

Inspired By Your Wellness

We are working together with government health systems, healthcare professionals, hospitals, associations, patients and their family members to target our 4 key goals.

We will change the lives of 5 million people.

22693

15%

Improved SGRQ Quality of Life After 1 Year

25%

Decreased COPD Hospital Readmission At 1 Year

70%

CPAP compliance

25%

Decreased COPD ER Visits At 1 Year

COPD & OSA Statistics

AT DIAGNOSIS, UP TO 50% OF LUNG FUNCTION MAY ALREADY HAVE BEEN LOST

COPD AFFECTS 210 MILLION PEOPLE WORLDWIDE

COPD – 3RD LEADING CAUSE OF DEATH IN THE WORLD BY 2020

COPD SYMPTOMS HAVE A DESTRUCTIVE IMPACT ON PATIENT FUNCTION & QUALITY OF LIFE. SHORTNESS OF BREATH IS ONE OF THE MOST BURDENSOME SYMPTOMS FOR COPD PATIENTS

20-40% OF PEOPLE WITH COPD ARE LIKELY TO RETIRE PREMATURELY DUE TO THEIR DISEASE

AROUND 25% OF ADULTS AGED 40 YEARS+ HAVE MILD AIRFLOW OBSTRUCTION

50% OF COPD SUFFERERS ARE LESS THAN 65 YEARS OLD & MAY BE AT THE PEAK OF THEIR EARNING POWER & FAMILY RESPONSIBILITIES

60-85% OF MILD TO MODERATE COPD PATIENTS ARE THOUGHT TO REMAIN UNDIAGNOSED

1 in 5 adults has mild OSA

1 in 15 has moderate to severe OSA

9% of women, 24% of men in middle-aged work force suffer from OSA

OSA Prevalence similar to asthma (17 million) and diabetes (15.7 million) Am Academy of Allergy, Asthma & Immunology; Am Diabetes Assoc

85% of OSA cases remain undiagnosed

Prior to apnea diagnosis, OSA patients utilized 23–50% more medical resources

Total economic cost of OSA sleepiness = approximately $43–56 billion

Undiagnosed moderate to severe sleep apnea in middle aged adults may cause $3.4 billion in additional medical costs in the US

For every dollar spent on CPAP treatment, $3.49 would be saved in reduced collision costs

Fifteen-fold increase of being involved in a traffic accident. Researchers estimated that the total cost of OSA-related accidents in 2000 was approximately $15.9 billion

Mission

Our movement will impact the world through our programs and education in sleep and respiratory health, delivered by a passionate multidisciplinary team.

Vision

Maple Respiratory Group is focused on programs, education and research that impact individuals who suffer from sleep disordered breathing and chronic lung disease. Our multidisciplinary healthcare team will change the lives of 5 million people by 2040.

Values

Opportunity

Create solutions. Embrace the future.

Accountability

Create simple, efficient expectations, act & communicate!

Autonomy

Act independently & inspire others.

Reflection

Our achievements will determine our future.

Relationships

Build authentic connections.

Balance

Work hard & celebrate hard!

Teamwork

Teamwork makes the dream work!